Hepatitis C Virus Infection
Conditions
Interventions
None listed
Sponsors
Gilead Sciences K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants must meet all the following inclusion/exclusion criteria. [Patients] 1)Age 18 and above. 2)Individuals who self-report past or present HCV infection including 1) patients who have received drug therapy for HCV within the past 5 years and 2) patients who have never received any drug therapy for HCV but still presently have HCV. 3)Able to provide informed consent to participate in the study and willing to participate in the study. [Physicians] 1)At least 3 years of clinical experience, including the period of clinical training. 2)Specializing in gastroenterology or gastroenterological surgery or general internal medicine. 3)Qualified as hepatologists by the Japan Society of Hepatology OR/AND gastroenterologists by the Japanese Society of Gastroenterology. 4)Having treated at least 1 patient with HCV and have prescribed drug therapy for HCV in the past. 5)Able to provide informed consent to participate in the study and willing to participate in the study.
Exclusion criteria
Exclusion criteria: [Patients] 1)Patients with suspected liver cirrhosis. 2)Patients with concomitant carcinoma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient and physician preferences regarding HCV treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Shared decision-making process for HCV treatment on patient and physician perspectives. | — |
Countries
Japan
Contacts
Public ContactMichael LOPRESTI
INTAGE Healthcare Inc. Value & Access Department
Outcome results
None listed